niacinamide has been researched along with tretinoin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 19 (55.88) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Inada, Y; Itaya-Hironaka, A; Kamiya, T; Tanaka, Y; Tsuyuki, M; Yoshihara, K | 1 |
| Davies, PJ; Johnson, GS; Lucas, DL; Tanuma, S; Wright, DG | 1 |
| Hoshino, S; Inageda, K; Kanaho, Y; Katada, T; Kontani, K; Kukimoto, I; Nishina, H; Takahashi, K; Tokita, K | 1 |
| Graeff, R; Lee, HC; Munshi, CB | 1 |
| Iwata, K; Ogata, S; Okumura, K; Taguchi, H | 1 |
| Kim, HJ; Kim, SH; Kim, TS | 1 |
| Arribas, MI; Jones, J; Leon-Quinto, T; Roche, E; Soria, B | 1 |
| Magnusson, KE; Merzvinskyte, R; Navakauskiene, R; Savickiene, J; Treigyte, G | 1 |
| Bi, Z; Cao, C; Kivlin, R; Lu, S; Pan, W; Song, X; Wallin, B; Wan, Y; Xu, A | 1 |
| Evans, TR; Roxburgh, P | 1 |
| Shen, M; Yen, A | 1 |
| Ahn, K; Heo, JI; Huh, SO; Jang, BG; Jeong, YJ; Jo, SA; Kang, HJ; Kim, J; Kim, JI; Kim, MJ; Kim, SC; Ko, YJ; Lee, JY; Lim, SS; Oh, SJ; Oh, SM; Park, JB; Park, SH; Suh, JG | 1 |
| Magnusson, KE; Navakauskiene, R; Savickiene, J; Treigyte, G | 1 |
| Bertucci, V; Fu, JJ; Grimes, PE; Hillebrand, GG; Kaczvinsky, JR; Li, J; Mandy, SH; Marmor, MJ; Perez, MI; Raleigh, P; Weinkle, SH | 1 |
| Magnusson, KE; Navakauskiene, R; Savickiene, J; Treigyte, G; Tunaitis, V; Vistartaite, G | 1 |
| Hirayama, M; Ichikawa, H; Nagai, M; Sasaki, K; Shirasawa, S; Tomotsune, D; Yokoyama, T; Yoshie, S; Yue, F | 1 |
| Açmaz, G; Akkar, OB; Atilgan, R; Boztosun, A; Kosar, MI; Ozer, H | 1 |
| Ferrero, S; Morotti, M | 1 |
| Mogi, A; Sasaki, K; Takizawa-Shirasawa, S; Tomotsune, D; Yokoyama, T; Yoshie, S; Yue, F | 1 |
| He, XD; Liu, H; Qin, SK; Tao, L; Tong, XH; Wang, ZS; Wu, Q; Yang, Y; Zheng, RS | 1 |
| Nair, GG; Odorico, JS; Vincent, RK | 1 |
| Delabesse, E; Guenounou, S; Récher, C | 1 |
| Ishijima, N; Kanki, K; Shimizu, H; Shiota, G | 1 |
| Gabrilove, J; Jing, Y; Wang, R; Waxman, S; Xia, L | 1 |
| Kaitsuka, T; Tomizawa, K | 1 |
| Aplan, PD; Bruner, JK; Duffield, AS; Ghiaur, G; Greenblatt, SM; Jones, RJ; Jung, E; Li, L; Ma, HS; Nguyen, B; Shirley, CM; Small, D | 1 |
| Rosamilia, LL | 1 |
| Bo, LS; Ke, WB; Li, T; Meng, YP; Zhang, Y | 1 |
| Chung, DH; Gius, D; Ozden, O; Park, SH; Paul, P; Qiao, J; Rellinger, EJ; Song, HY; Vasilopoulos, A | 1 |
| Campuzano-García, AE; Castanedo-Cázares, JP; Cortés-García, JD; Fuentes-Ahumada, C; Hernández-Blanco, D; Torres-Alvarez, B | 1 |
| Liu, GJ; Liu, H; Liu, L; Peinemann, F; Sang, H; Xia, J; Yu, H | 1 |
| Adams-Woodford, A; Ayres, P; Diaz, I; Giancola, G; Handler, M | 1 |
5 review(s) available for niacinamide and tretinoin
| Article | Year |
|---|---|
Role of small bioorganic molecules in stem cell differentiation to insulin-producing cells.
Topics: Alkaloids; Androstadienes; Animals; Butyrates; Cell Differentiation; Chromones; Enzyme Inhibitors; Glucose; Humans; Insulin; Insulin Antagonists; Morpholines; Niacinamide; Stem Cells; Tretinoin; Wortmannin | 2006 |
Systemic therapy of hepatocellular carcinoma: are we making progress?
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Estrogens; Humans; Injections, Intravenous; Interferons; Liver Neoplasms; Niacinamide; Palliative Care; Phenylurea Compounds; Pyridines; Risk Factors; Sorafenib; Tretinoin | 2008 |
Cell-Penetrating Peptide as a Means of Directing the Differentiation of Induced-Pluripotent Stem Cells.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell-Penetrating Peptides; Cellular Reprogramming; Cinnamates; Gene Expression; Glucagon-Like Peptide 1; Homeodomain Proteins; Humans; Induced Pluripotent Stem Cells; Insulin-Secreting Cells; Intercellular Signaling Peptides and Proteins; Maf Transcription Factors, Large; Mice; Nerve Tissue Proteins; Niacinamide; Trans-Activators; Tretinoin; Veratrum Alkaloids | 2015 |
Over-the-counter treatments for acne and rosacea.
Topics: Acne Vulgaris; Administration, Cutaneous; Astringents; Benzoyl Peroxide; Dermatologic Agents; Detergents; Evidence-Based Medicine; Global Health; Humans; Hydroxy Acids; Kinetin; Niacinamide; Nonprescription Drugs; Phototherapy; Randomized Controlled Trials as Topic; Resorcinols; Rosacea; Salicylates; Sulfur; Sunscreening Agents; Tea Tree Oil; Treatment Outcome; Tretinoin; Zinc | 2016 |
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Bias; Child; Clindamycin; Dermatologic Agents; Dicarboxylic Acids; Erythromycin; Female; Glycolates; Humans; Keratolytic Agents; Male; Mandelic Acids; Niacinamide; Patient Dropouts; Pyruvic Acid; Quality of Life; Salicylic Acid; Sulfur; Tretinoin; Young Adult; Zinc | 2020 |
2 trial(s) available for niacinamide and tretinoin
| Article | Year |
|---|---|
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
Topics: Administration, Topical; Adult; Aged; Cosmetics; Dermatologic Agents; Diterpenes; Emollients; Face; Female; Humans; Middle Aged; Niacinamide; Peptides; Retinyl Esters; Skin Aging; Skin Care; Treatment Outcome; Tretinoin; Vitamin A | 2010 |
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo.
Topics: 5-Methylcytosine; Adult; DNA Methylation; DNA Modification Methylases; Epidermis; Female; Fluorescence; Gene Expression Regulation, Enzymologic; Humans; Melanosis; Niacinamide; Placebos; Sunscreening Agents; Tretinoin | 2019 |
27 other study(ies) available for niacinamide and tretinoin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Retinoic acid-induced differentiation-specific, C-kinase-dependent phosphorylation of cytosolic 44 and 32 kDa proteins in HL-60 cells.
Topics: Benzamides; Bucladesine; Calcium; Cell Differentiation; Cell Extracts; Cells, Cultured; Cytosol; Dimethyl Sulfoxide; Electrophoresis, Polyacrylamide Gel; Humans; Molecular Weight; Niacinamide; Phosphorylation; Protein Kinase C; Proteins; Tretinoin | 1990 |
Maturation of human promyelocytic leukemia cells induced by nicotinamide: evidence of a regulatory role for ADP-ribosylation of chromosomal proteins.
Topics: Acyltransferases; Adenosine Diphosphate Ribose; Cell Division; Cell Line; Cell Nucleus; Humans; Kinetics; Leukemia, Myeloid, Acute; NAD+ Nucleosidase; Niacinamide; Nucleoproteins; Nucleoside Diphosphate Sugars; Phagocytosis; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerases; Transglutaminases; Tretinoin | 1984 |
Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Amino Acid Sequence; Animals; Antigens, CD; Antigens, Differentiation; Antigens, Surface; Aplysia; Catalysis; Enzyme Induction; Gonads; Molecular Sequence Data; N-Glycosyl Hydrolases; NAD+ Nucleosidase; Niacinamide; Sequence Homology, Amino Acid; Substrate Specificity; Tretinoin | 1995 |
Evidence for a causal role of CD38 expression in granulocytic differentiation of human HL-60 cells.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Calcium; Cell Differentiation; Cell Separation; Cyclic ADP-Ribose; Doxycycline; Enzyme Inhibitors; Flow Cytometry; HL-60 Cells; Humans; Liposomes; Membrane Glycoproteins; Microscopy, Fluorescence; Niacinamide; Oligonucleotides, Antisense; Plasmids; RNA; RNA Interference; Time Factors; Tretinoin | 2002 |
Expression of CD38 in human promyelocytic leukemia HL-60 cell line during differentiation by niacin-related compounds.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Cell Differentiation; Cell Membrane; Flow Cytometry; Gene Expression; HL-60 Cells; Humans; Isonicotinic Acids; Membrane Glycoproteins; Niacinamide; Tretinoin | 2003 |
Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin.
Topics: Artemisinins; Cell Differentiation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Protein Kinase C; Sesquiterpenes; Tretinoin | 2003 |
Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells.
Topics: Cell Differentiation; Drug Combinations; Granulocytes; Histone Deacetylase Inhibitors; Histone Deacetylases; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Phenylbutyrates; Tretinoin | 2006 |
Nicotinamide attenuates aquaporin 3 overexpression induced by retinoic acid through inhibition of EGFR/ERK in cultured human skin keratinocytes.
Topics: Animals; Aquaporin 3; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Keratinocytes; Keratolytic Agents; MAP Kinase Signaling System; Niacinamide; Permeability; RNA Interference; Skin; Tretinoin; Vitamin B Complex | 2008 |
Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.
Topics: ADP-ribosyl Cyclase 1; Calcitriol; CD11b Antigen; Cell Cycle; Cell Differentiation; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myelomonocytic, Acute; Lipopolysaccharide Receptors; Niacinamide; Tretinoin | 2009 |
SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Collagen Type XI; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Neoplasm Proteins; Neuroblastoma; Neurons; Niacinamide; Sirtuin 1; Sirtuins; Tretinoin; Tyrosine 3-Monooxygenase; Vitamin B Complex | 2009 |
Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
Topics: Acetylation; Anilides; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin-Dependent Kinase Inhibitor p21; Depsipeptides; Drug Resistance, Neoplasm; Drug Synergism; Electrophoretic Mobility Shift Assay; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Niacinamide; Phenylbutyrates; Promoter Regions, Genetic; Protein Binding; Tretinoin; Tumor Suppressor Protein p53; Vitamin B Complex | 2009 |
C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Topics: Acetylation; Blotting, Western; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Chromatin Assembly and Disassembly; Chromatin Immunoprecipitation; Flow Cytometry; Gene Expression; Granulocytes; Histone Deacetylase Inhibitors; Histones; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Elastase; Niacinamide; Promoter Regions, Genetic; Proto-Oncogene Proteins; Receptors, Granulocyte Colony-Stimulating Factor; Trans-Activators; Tretinoin | 2011 |
Pancreatic exocrine enzyme-producing cell differentiation via embryoid bodies from human embryonic stem cells.
Topics: Activins; Amylases; Carboxypeptidases A; Cell Culture Techniques; Cell Differentiation; Chymotrypsin; Embryoid Bodies; Embryonic Stem Cells; Fibroblast Growth Factor 7; Glucagon-Like Peptide 1; Hepatocyte Nuclear Factor 3-beta; Humans; Lipase; Niacinamide; Pancreas, Exocrine; Pancreatic Elastase; SOXF Transcription Factors; Tretinoin | 2011 |
The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Disease Models, Animal; Endometriosis; Female; Microvessels; Niacinamide; Phenylurea Compounds; Random Allocation; Rats; Rats, Wistar; Sorafenib; Treatment Outcome; Tretinoin | 2013 |
Antiangiogenic drugs in the treatment of endometriosis.
Topics: Animals; Antibodies, Monoclonal, Humanized; Disease Models, Animal; Endometriosis; Female; Niacinamide; Phenylurea Compounds; Tretinoin | 2013 |
FGF7 and cell density are required for final differentiation of pancreatic amylase-positive cells from human ES cells.
Topics: Activins; Amylases; Cell Communication; Cell Count; Cell Culture Techniques; Cell Differentiation; Cells, Cultured; Cytological Techniques; Embryonic Stem Cells; Fibroblast Growth Factor 7; Glucagon-Like Peptide 1; Humans; Niacinamide; Pancreas, Exocrine; Tretinoin | 2013 |
Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Communication; Cell Line, Tumor; Cell Proliferation; Connexins; Drug Synergism; Gap Junctions; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Niacinamide; Oleic Acids; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Tretinoin | 2014 |
Ectopic Ptf1a expression in murine ESCs potentiates endocrine differentiation and models pancreas development in vitro.
Topics: Animals; Blotting, Western; Cell Differentiation; Cell Line; Cell Lineage; Embryonic Stem Cells; Endocrine Cells; Gene Expression Regulation, Developmental; Homeodomain Proteins; Insulin; Mice; Microscopy, Electron; Microscopy, Fluorescence; Models, Genetic; Niacinamide; Organogenesis; Pancreas; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Trans-Activators; Transcription Factors; Tretinoin | 2014 |
Sorafenib plus all-trans retinoic acid for AML patients with FLT3-ITD and NPM1 mutations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Niacinamide; Nuclear Proteins; Nucleophosmin; Phenylurea Compounds; Sorafenib; Treatment Outcome; Tretinoin; Young Adult | 2014 |
Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzoates; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Retinoids; Sorafenib; Tetrahydronaphthalenes; Tretinoin | 2015 |
Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Sorafenib; Tretinoin; Xenograft Model Antitumor Assays | 2016 |
All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo.
Topics: Animals; Cell Death; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; fms-Like Tyrosine Kinase 3; Gene Duplication; Humans; Leukemia, Myeloid, Acute; Mice; Mutant Proteins; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib; Tandem Repeat Sequences; Tretinoin; Xenograft Model Antitumor Assays | 2016 |
miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mice, Nude; MicroRNAs; Nanoparticles; Niacinamide; Phenylurea Compounds; Sorafenib; Stomach Neoplasms; Tretinoin | 2017 |
Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Knockdown Techniques; Humans; Neuroblastoma; Niacinamide; RNA, Small Interfering; Sirtuins; Tretinoin | 2018 |
Facial Aging Improvement Case Study Using a Novel Combination of Retinol, Niacinamide, and Terminalia Chebula.
Topics: Aging; Humans; Niacinamide; Retinoids; Skin Aging; Terminalia; Tretinoin; Vitamin A | 2022 |